Cargando…
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer
The purpose of this study was to evaluate the efficacy, assesed as response rate, and toxicity of UFT (Tegafur-Uracil) in combination with oxaliplatin as first-line treatment of advanced colorectal cancer (CRC). In all, 84 patients with recurrent or metastatic CRC with measurable disease were includ...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410059/ https://www.ncbi.nlm.nih.gov/pubmed/15505621 http://dx.doi.org/10.1038/sj.bjc.6602217 |